Companies to Watch – Cellarity
Fabrice Chouraqui, CEO of Cellarity, speaks about the company’s approach to drug discovery, the technology it is harnessing, and why focusing on cells rather than molecular targets are a better way to discover drugs.
This is part of the Big4Bio Company to Watch program for March 2022: Cellarity
For more information on the series, click here.